| Literature DB >> 36072871 |
Maurice Pradella1,2, Rita Achermann1, Jonathan I Sperl3, Rainer Kärgel3, Saikiran Rapaka4, Joshy Cyriac1, Shan Yang1, Gregor Sommer1,5, Bram Stieltjes1, Jens Bremerich1, Philipp Brantner1,6, Alexander W Sauter1,7.
Abstract
Purpose: Thoracic aortic (TA) dilatation (TAD) is a risk factor for acute aortic syndrome and must therefore be reported in every CT report. However, the complex anatomy of the thoracic aorta impedes TAD detection. We investigated the performance of a deep learning (DL) prototype as a secondary reading tool built to measure TA diameters in a large-scale cohort. Material and methods: Consecutive contrast-enhanced (CE) and non-CE chest CT exams with "normal" TA diameters according to their radiology reports were included. The DL-prototype (AIRad, Siemens Healthineers, Germany) measured the TA at nine locations according to AHA guidelines. Dilatation was defined as >45 mm at aortic sinus, sinotubular junction (STJ), ascending aorta (AA) and proximal arch and >40 mm from mid arch to abdominal aorta. A cardiovascular radiologist reviewed all cases with TAD according to AIRad. Multivariable logistic regression (MLR) was used to identify factors (demographics and scan parameters) associated with TAD classification by AIRad.Entities:
Keywords: aorta - thoracic; aortic aneurysm (thoracic); artifical intelligence (AI); computed tomography; deep learning; diameter measurement; dilatation; guidelines
Year: 2022 PMID: 36072871 PMCID: PMC9441594 DOI: 10.3389/fcvm.2022.972512
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Flow chart. † <45 mm for aortic sinus, sinotubular junction, ascending aorta and proximal arch or <40 mm at mid and distal arch, mid and distal descending aorta and abdominal aorta. AHA, American Heart Association; CV, cardiovascular.
Figure 2Example case. AIRad produced visual outputs consisting of a sagittal view on the thoracic aorta (A) and a 3D volume rendering (B) with all measured locations (C1–C9). Furthermore, images of the measurements perpendicular to the centerline at each of the nine locations according to the AHA guidelines were also created, as seen in this example of an exam in pulmonary-arterial phase. AHA, American Heart Association.
Baseline characteristics for the entire cohort.
|
| |
|---|---|
| Number of scans | 18,243 |
| Age (years) | 62.3 ± 15.9 |
| Female sex | 8,330 (45.7%) |
| Weight (kg) | 74 ± 17.2 |
| Height (m) | 1.7 ± 0.1 |
| BMI (kg/m2) | 25.6 ± 5.4 |
|
| |
| CT chest | 13,260 (72.7%) |
| CT chest + abdomen | 4,983 (27.3%) |
|
| |
| Non-contrast | 5,935 (32.5%) |
| Arterial phase | 2,233 (12.2%) |
| Pulmonary-arterial phase | 4,203 (23%) |
| Venous phase | 4,888 (26.8%) |
| Mixed contrast phase | 768 (4.2%) |
| Other | 216 (1.2%) |
| Scan with ECG-triggering | 153 (0.8%) |
| DLP (mGycm) | 330.4 ± 385.7 |
Reviewed cohort, differences between true positive and false positive cases.
|
|
|
|
| |
|---|---|---|---|---|
| Number of scans | 1,004 | 452 (45%) | 552 (55%) | – |
| Age (years) | 68.2 ± 12.4 | 68.3 ± 11.3 | 68.1 ± 13.2 | 0.85 |
| Female sex | 136 | 41 (30.1%) | 95 (69.9%) |
|
| BMI (kg/m2) | 27 ± 5.3 | 27.9 ± 5.5 | 26.2 ± 4.9 |
|
|
| ||||
| Non-contrast | 598 | 224 (37.5%) | 374 (62.5%) |
|
| Arterial phase | 59 | 27 (45.8%) | 32 (54.2%) | 1.0 |
| Pulmonary-arterial phase | 114 | 73 (64%) | 41 (36%) |
|
| Venous phase | 193 | 107 (55.4%) | 86 (44.6%) |
|
| Mixed contrast phase | 27 | 16 (59.3%) | 11 (40.7%) | 0.18 |
| Other | 13 | 5 (38.5%) | 8 (61.5%) | 0.78 |
| Scan with ECG-triggering | 9 | 1 (11.1%) | 8 (88.9%) | 0.09 |
| DLP (mGycm) | 343.2 ± 377 | 374.8 ± 369.2 | 317 ± 381.8 | 0.07 |
|
| ||||
| AS | 556 | 256 (46%) | 300 (54%) | 0.35 |
| STJ | 196 | 120 (61.2%) | 76 (38.8%) |
|
| AA | 414 | 250 (60.4%) | 164 (39.6%) |
|
| PA | 48 | 27 (56.3%) | 21 (43.8%) | 0.13 |
| MA | 105 | 42 (40%) | 63 (60%) | 0.37 |
| DA | 68 | 32 (47.1%) | 36 (52.9%) | 0.77 |
| MDA | 27 | 7 (25.9%) | 20 (74.1%) | 0.07 |
| DDA | 40 | 14 (35%) | 26 (65%) | 0.28 |
| ABA | 34 | 5 (14.7%) | 29 (85.3%) |
|
|
| ||||
| 1 | 612 | 244 (39.9%) | 368 (60.1%) |
|
| 2 | 198 | 106 (53.5%) | 92 (46.5%) |
|
| 3 | 79 | 53 (67.1%) | 26 (32.9%) |
|
| 4 | 19 | 14 (73.7%) | 5 (26.3%) |
|
| 5 | 7 | 5 (71.4%) | 2 (28.6%) | 0.26 |
Demographics, CT scan parameters and location-specific information on all cases reported as dilated by AIRad.
AA, ascending aorta; AS, aortic sinus; BMI, body mass index; DA, distal arch; DDA, distal descending aorta; DLP, dose length product; ECG, electrocardiogram; MA, mid arch; MDA, mid descending aorta; PA, proximal arch; STJ, sinotubular junction. Bold p values were statistically significant.
Mean diameters per location in the true positive, false positive and non-dilated cohorts.
|
|
|
| |
|---|---|---|---|
| Number of cases | 452 | 552 | 17,239 |
|
| |||
| AS (mm) | 44.42 ± 4.33 | 43.98 ± 4.75 | 35.20 ± 4.39 |
| STJ (mm) | 42.51 ± 4.03 | 40.74 ± 4.10 | 33.49 ± 4.01 |
| AA (mm) | 44.63 ± 3.55 | 42.78 ± 3.72 | 35.69 ± 4.14 |
| PA (mm) | 40.21 ± 3.27 | 39.02 ± 3.50 | 33.07 ± 3.82 |
| MA (mm) | 36.13 ± 3.06 | 35.62 ± 3.42 | 30.25 ± 3.49 |
| DA (mm) | 33.89 ± 3.91 | 33.76 ± 5.27 | 28.14 ± 3.34 |
| MDA (mm) | 31.67 ± 3.28 | 31.59 ± 4.67 | 26.54 ± 3.51 |
| DDA (mm) | 31.13 ± 3.95 | 31.40 ± 4.97 | 26.11 ± 3.75 |
| ABA (mm) | 29.37 ± 4.17 | 29.90 ± 5.76 | 25.12 ± 3.79 |
Mean diameters and standard deviation per location for true positive, false positive and negative cases.
AA, ascending aorta; ABA, abdominal aorta; AS, aortic sinus; DA, distal arch; DDA, distal descending aorta; MA, mid arch; MDA, mid descending aorta; PA, proximal arch; STJ, sinotubular junction.
Figure 3Examples of true positive cases. (A) This case shows dilatation of the AS (49 mm) in venous phase CT of a 57-year-old male patient detected by AIRad. (B) In this non-CE exam, dilatation of the AA (51 mm) was found in a 54-year-old male patient. (C) Similar to B but in pulmonary-arterial phase, AA dilatation (49 mm) in a 66-year-old male was revealed by AIRad. (D) Dilatation of the DA (41 mm) was identified by AIRad in a pulmonary-arterial phase CT of a 56-year-old female patient. AA, ascending aorta; AS, aortic sinus; CE, contrast enhanced; DA, distal arch.
Figure 4Examples of false positive cases. (A) Due to an error in centerline placement, the AS plane was tilted and falsely contoured, resulting in a false-high measurement in this pulmonary-arterial scan of a 93-year-old female patient. (B) In this non-CE scan of an 82-year-old female patient, the contouring at the AA location was too wide, resulting in a false-high measurement. (C) The CT in pulmonary-arterial phase of 75-year-old male patient showed an aberrant right subclavian arteria. This caused an error contouring the location of the DA, resulting in a false-high measurement. (D) The last two locations (DDA, ABA) in the pulmonary-arterial phase CT of an 85-year-old female patient were tilted caused by an erroneous centerline placement, resulting in a false-high measurement at DDA (42 mm). AA, ascending aorta; ABA, abdominal aorta; AS, aortic sinus; CE, contrast enhanced; DA, distal arch; DDA, distal descending aorta.
MLRM Model 1 to differentiate between AIRad_positive vs. AIRad_negative.
|
|
|
| |
|---|---|---|---|
| (Intercept) | 0.000031 | 0–0.0002 |
|
| Age | 1.04 | 1.03–1.04 |
|
| Male sex | 10.11 | 7.05–15.06 |
|
| BMI | 1.09 | 1.06–1.11 |
|
|
| |||
| Arterial phase | 0.31 | 0.19–0.46 |
|
| Pulmonary-arterial phase | 0.4 | 0.29–0.55 |
|
| Venous phase | 0.43 | 0.28–0.65 |
|
| Mixed contrast phase | 0.6 | 0.34–0.99 | 0.06 |
| Other | 0.64 | 0.19–1.57 | 0.4 |
| Scan with ECG-triggering | 2.65 | 0.55–47.72 | 0.34 |
| DLP | 1 | 0.9997–1 | 0.73 |
Results from the MLRM Model 1 showed that cases reported as dilated (AIRad_positive) were more likely older, male patients with higher BMI. Furthermore, dilatation was less often reported in contrast-enhanced scans.
BMI, body mass index; DLP, dose length product; ECG, electrocardiogram; MLRM, multivariable logistic regression model. Bold p values were statistically significant.
MLRM 2 to differentiate between true positive vs. false positive cases.
|
|
|
| |
|---|---|---|---|
| (Intercept) | 0.000056 | 0–0.0041 |
|
| Age | 1 | 0.98–1.01 | 0.6 |
| Male sex | 2.36 | 1.36–4.19 |
|
| BMI | 1.05 | 1.01–1.08 |
|
|
| |||
| Arterial phase | 2.08 | 0.97–4.45 | 0.06 |
| Pulmonary-arterial phase | 2.92 | 1.61–5.44 |
|
| Venous phase | 2.48 | 1.21–5.13 |
|
| Mixed contrast phase | 3.07 | 1.21–8.16 |
|
| Other | 1.64 | 0.36–7.56 | 0.51 |
| Scan with ECG-triggering | 3.68 | 0.39–82.52 | 0.3 |
| DLP | 1 | 1–1 | 0.29 |
|
| |||
| AS | 0.94 | 0.9–0.99 |
|
| STJ | 1.09 | 1.03–1.15 |
|
| AA | 1.12 | 1.06–1.19 |
|
| PA | 1.04 | 0.96–1.13 | 0.35 |
| MA | 0.95 | 0.87–1.03 | 0.21 |
| DA | 1.01 | 0.96–1.06 | 0.73 |
| Dilatation found at higher number of locations | 1.42 | 1.1–1.84 |
|
MLRM 2 revealed that dilatation reported by AIRad was more likely to be correct in male patients with higher BMI, when contrast was administered as well as when dilatation was reported at AS, STJ, AA and at more than one location.
AA, ascending aorta; AS, aortic sinus; BMI, body mass index; DA, distal arch; DDA, distal descending aorta; DLP, dose length product; ECG, electrocardiogram; MA, mid arch; MDA, mid descending aorta; MLRM, multivariable logistic regression model; PA, proximal arch; STJ, sinotubular junction. Bold p values were statistically significant.